Syncom Form Peer Comparison

NSE: SYNCOMF | BSE: 524470

₹19.46

₹2.12 (12.23%)

As on 28-Aug-2026IST

Market cap

₹1,829 Cr

Revenue (TTM)

₹498 Cr

P/E Ratio

21.4

P/B Ratio

4.2

Div. Yield

0 %

Edit

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Market cap (₹ Cr)	1,829	21,501	19,125	18,253	17,766
Revenue (₹ Cr)	498	2,570	2,287	3,230	2,432
Net Profit (₹ Cr)	85.53	735.15	678.07	666.92	169.62
Net Margin (%)	16.11	26.88	28.10	20.60	6.90
RoE (%)	21.56	19.16	19.73	18.75	20.76
Price to Earnings	21.39	29.25	28.74	28.35	104.74
Price-To-Book	4.16	4.88	5.08	4.51	19.65

Income Statement (₹ Cr)

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Operating Revenue	494.69	2,569.77	2,287.33	3,229.67	2,432.06
Total Income	527.45	2,735.39	2,413.29	3,237.12	2,458.54
Total Expenditure	407.44	1,628.14	1,490.75	2,090.06	2,202.20
EBITDA	87.25	941.63	796.58	1,139.61	229.86
Depreciation	6.73	57.58	78.10	281.06	17.24
EBIT	80.52	884.05	718.48	858.55	212.62
Interest	1.10	7.69	0.88	190.64	5.72
Other Income	32.76	165.62	125.96	7.45	26.48
Exceptional Items	0.00	-49.16	0.00	-17.24	-5.13
Profit before Tax	112.18	992.82	843.56	658.12	228.25
Provision for Tax	27.31	257.67	165.49	-8.80	58.63
Profit after Tax	84.87	735.15	678.07	666.92	169.62

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Shareholder's Funds	412.30	4,202.90	3,586.42	3,902.67	872.79
Minority Interest	0.00	0.00	-12.71	-21.81	0.00
Non-Current Liabilities	15.13	91.50	28.74	1,392.75	134.50
Current Liabilities	101.83	627.48	385.94	2,077.10	981.81
Total Liabilities	--	4,911.11	3,207.85	6,862.28	1,879.19

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Non-Current Assets	186.08	770.28	1,291.22	5,617.77	42.47
Current Assets	326.03	3,803.22	2,585.66	1,539.85	1,739.93
Total Assets	--	4,911.11	3,207.85	6,862.28	1,879.19
Total Debt*	--	2.50	0.55	2,421.66	0.00
Net Current Assets	224.21	3,175.74	2,199.72	-537.25	758.12
Contingent Liabilities	--	363.79	0.64	64.29	98.41

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Cash From Operating Activities	--	659.75	432.37	1,065.01	65.36
Cash Flow from Investing Activities	--	-71.34	-334.73	-79.97	30.80
Cash from Financing Activities	--	-205.34	-38.32	-881.32	-65.59
Net Cash Inflow / Outflow	--	383.07	59.32	103.72	30.57

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
ROCE (%)	--	26.21	26.22	13.59	21.29
ROE (%)	21.52	19.16	19.73	18.75	20.76
ROA (%)	18.08	14.95	18.69	9.26	9.67
EBIT Margin (%)	16.28	34.40	31.41	26.58	8.74
Net Margin (%)	16.09	26.88	28.10	20.60	6.90
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Revenue Growth (%)	0.23	10.69	15.01	9.59	31.10
EBIT Growth (%)	47.62	24.14	18.45	16.84	-12.99
Net Profit Growth (%)	48.97	-9.09	19.61	62.68	-7.49
EPS Growth (%)	49.07	14.40	17.73	67.41	-18.33
Book Value Growth (%)	--	17.30	23.77	10.19	7.70

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Price / Earnings	21.55	27.87	28.74	27.66	102.37
Price / Book Value	4.19	4.88	5.08	4.51	19.65
Dividend Yield (%)	0.00	1.60	0.16	0.55	0.51
EV/EBITDA	19.99	19.53	22.88	17.94	75.34
Market Cap (₹ Cr)	--	18,318.10	15,219.80	19,292.77	21,515.93

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Debt to Equity	0.00	0.00	0.00	0.24	0.00
Short term debt to equity ratio	--	0.00	0.00	0.14	--
Current Ratio	3.20	6.06	6.70	0.74	1.77
Quick Ratio	2.58	5.31	5.59	0.53	0.73
Interest Coverage	103.26	130.11	959.59	4.45	40.90

	Syncom Form	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Debtors to sales (%)	21.75	7.07	36.10	21.07	8.79
Asset Turnover	1.05	0.52	0.63	0.45	1.39
Receivable days	--	29.10	110.70	54.07	35.81
Inventory Days	--	69.53	65.86	32.16	82.25
Payable days	--	76.77	105.88	140.91	124.39
Cash Conversion Cycle	--	21.86	70.68	-54.68	-6.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.